Holen Sie sich die Stockscreener-App
5.23
1.32%
-0.07
Schlusskurs vom Vortag:
$5.30
Offen:
$5.36
24-Stunden-Volumen:
26,059
Relative Volume:
1.30
Marktkapitalisierung:
$47.02M
Einnahmen:
$23.84M
Nettoeinkommen (Verlust:
$-3.81M
KGV:
-10.46
EPS:
-0.5
Netto-Cashflow:
$-713.00K
1W Leistung:
+3.08%
1M Leistung:
-4.74%
6M Leistung:
+44.88%
1J Leistung:
+8.96%
1-Tages-Spanne:
$5.2088
$5.48
1-Wochen-Bereich:
$4.7784
$5.55
52-Wochen-Spanne:
$3.34
$5.82
Immucell Corp Stock (ICCC) Company Profile
Firmenname
Immucell Corp
Sektor
Branche
Telefon
(207) 878-2770
Adresse
56 EVERGREEN DR, PORTLAND, ME
Vergleichen Sie ICCC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICCC
Immucell Corp
|
5.23 | 46.23M | 23.84M | -3.81M | -713.00K | -0.50 |
|
ONC
Beigene Ltd Adr
|
227.84 | 25.49B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.20 | 110.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 38.69M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
592.02 | 59.13B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
71.19 | 5.64B | 0 | -153.72M | -103.81M | -2.00 |
Immucell Corp Aktie (ICCC) Neueste Nachrichten
ImmuCell Corporation (NASDAQ:ICCC) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call transcript: ImmuCell’s Q1 2025 revenue hits record, stock surges - Investing.com
ImmuCell Q2 2025 slides: sales momentum continues as Re-Tain awaits FDA approval - Investing.com
ImmuCell Corporation Q1 2025 Financial Results - TradingView
ImmuCell To Announce Unaudited Financial Results For the Quarter Ended March 31, 2025 - Barchart.com
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025 - Stock Titan
Geode Capital Management LLC Boosts Stock Holdings in ImmuCell Co. (NASDAQ:ICCC) - Defense World
ImmuCell Co. (NASDAQ:ICCC) Short Interest Update - Defense World
ImmuCell (NASDAQ:ICCC) Stock Crosses Above 200-Day Moving Average – Should You Sell? - Defense World
The Zacks Analyst Blog Netflix, SAP SE, Shell, Preformed Line Products and ImmuCell - Yahoo Finance
ImmuCell (NASDAQ:ICCC) Stock Crosses Above 200 Day Moving Average – What’s Next? - Defense World
ImmuCell reports record sales in first quarter of 2025 - Investing.com
Record Quarter: ImmuCell Crushes Sales Estimates with $8.1M Revenue Milestone - Stock Titan
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025 - The Globe and Mail
ImmuCell appoints new CFO to bolster growth strategy - Investing.com
ImmuCell Strengthens Leadership: 24-Year IDEXX Finance Expert Takes CFO Role - Stock Titan
ImmuCell Hires Chief Financial Officer - The Globe and Mail
ImmuCell Full Year 2024 Earnings: US$0.26 loss per share (vs US$0.74 loss in FY 2023) - Yahoo Finance
Revolutionary Antibiotic-Free Mastitis Treatment Enters Market Testing Phase - Stock Titan
IMMUCELL CORP /DE/ SEC 10-K Report - TradingView
ImmuCell (NASDAQ:ICCC) Stock Passes Above 200 Day Moving Average – Time to Sell? - Defense World
ImmuCell (NASDAQ:ICCC) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World
ImmuCell Corp. to Host Earnings Call - ACCESS Newswire
ImmuCell Posts Y/Y Q4 Earnings Growth, Awaits FDA Approval For Re-Tain - Barchart.com
ImmuCell Corp (ICCC) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Operational ... By GuruFocus - Investing.com Canada
ImmuCell Corporation (NASDAQ:ICCC) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call transcript: ImmuCell sees strong Q4 2024 sales growth - Investing.com
ImmuCell Corporation Reports Strong Financial Performance for Q4 and Full Year 2024 - TradingView
Animal Health Pioneer ImmuCell Sets Stage for Critical Year-End Financial Reveal - StockTitan
The Zacks Analyst Blog Highlights Apple, Eli Lilly, Shopify and ImmuCell - Yahoo Finance
Top Stock Reports for Apple, Eli Lilly & Shopify - Yahoo Finance
ImmuCell (NASDAQ:ICCC) Stock Price Passes Above 200-Day Moving Average – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
ImmuCell (NASDAQ:ICCC) Stock Passes Above 200 Day Moving Average – What’s Next? - Defense World
ImmuCell Settles Insurance Claim for Production Contamination Events - Defense World
ImmuCell settles insurance claim for production losses - Investing.com
ImmuCell Secures $426,587 Additional Insurance Settlement for Production Contamination Issues - StockTitan
ImmuCell Announces Strong Preliminary Sales Results for Q4 and Full Year 2024 - Defense World
ImmuCell Sales Surge 52% to Record $26.5M as Production Hits Full Capacity - StockTitan
ImmuCell (NASDAQ:ICCC) Shares Pass Above 200 Day Moving Average – Here’s What Happened - Defense World
ImmuCell announces executive transition with part-time agreement By Investing.com - Investing.com South Africa
ImmuCell announces executive transition with part-time agreement - Investing.com
Zacks Initiates Coverage of ImmuCell With Neutral Recommendation - Yahoo Finance
The Zacks Analyst Blog Highlights Amazon.com, Stryker, Lam Research and ImmuCell - Yahoo Finance
Top Research Reports for Amazon, Stryker & Lam Research - Yahoo Finance
ImmuCell amends agreement with Norbrook Labs - Investing.com
ImmuCell Q3 Earnings Decline Y/Y, Sales Grow Amid Margin Challenges - MSN
Finanzdaten der Immucell Corp-Aktie (ICCC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.51%
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):